tradingkey.logo

Stryker Corp

SYK

363.690USD

-1.600-0.43%
Close 03/12, 16:00ETQuotes delayed by 15 min
138.71BMarket Cap
46.35P/E TTM

Stryker Corp

363.690

-1.600-0.43%
More Details of Stryker Corp Company
Company Info
Company codeSYK
Company nameStryker Corp
IPO dateMar 17, 1980
Founded at1946
CEOMr. Kevin A. Lobo
Number of employees53000
Security typeOrdinary Share
Fiscal year-endMar 17
Address1941 Stryker Way
CityPORTAGE
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code49002
Phone12693852600
Websitehttps://www.stryker.com/
Company codeSYK
IPO dateMar 17, 1980
Founded at1946
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Kevin A. Lobo
Mr. Kevin A. Lobo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
100.60K
--
Ms. Ronda E. Stryker
Ms. Ronda E. Stryker
Independent Director
Independent Director
95.58K
+4.13%
Mr. Spencer S. Stiles
Mr. Spencer S. Stiles
Group President - Orthopaedics and Spine
Group President - Orthopaedics and Spine
55.70K
+9.35%
Ms. Yin C. Becker
Ms. Yin C. Becker
Vice President - Chief Corporate Affairs Officer
Vice President - Chief Corporate Affairs Officer
32.19K
+6.80%
Mr. Allan C. Golston, CPA
Mr. Allan C. Golston, CPA
Independent Director
Independent Director
12.41K
--
Mr. Viju S. Menon
Mr. Viju S. Menon
Group President - Global Quality and Operations
Group President - Global Quality and Operations
7.95K
-7.02%
Mr. Robert S. Fletcher
Mr. Robert S. Fletcher
Vice President, Chief Legal Officer
Vice President, Chief Legal Officer
6.87K
+4.34%
Ms. Mary K. Brainerd
Ms. Mary K. Brainerd
Independent Director
Independent Director
5.76K
+12.78%
Mr. Glenn S. Boehnlein, CPA
Mr. Glenn S. Boehnlein, CPA
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
5.43K
+16.13%
Mr. Rajeev Suri
Mr. Rajeev Suri
Independent Director
Independent Director
5.16K
+14.48%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Kevin A. Lobo
Mr. Kevin A. Lobo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
100.60K
--
Ms. Ronda E. Stryker
Ms. Ronda E. Stryker
Independent Director
Independent Director
95.58K
+4.13%
Mr. Spencer S. Stiles
Mr. Spencer S. Stiles
Group President - Orthopaedics and Spine
Group President - Orthopaedics and Spine
55.70K
+9.35%
Ms. Yin C. Becker
Ms. Yin C. Becker
Vice President - Chief Corporate Affairs Officer
Vice President - Chief Corporate Affairs Officer
32.19K
+6.80%
Mr. Allan C. Golston, CPA
Mr. Allan C. Golston, CPA
Independent Director
Independent Director
12.41K
--
Mr. Viju S. Menon
Mr. Viju S. Menon
Group President - Global Quality and Operations
Group President - Global Quality and Operations
7.95K
-7.02%
Revenue Breakdown
Currency: USDUpdate time: Wed, Mar 5
Currency: USDUpdate time: Wed, Mar 5
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Medical
3.85B
17.04%
Trauma and Extremities
3.50B
15.52%
Endoscopy
3.38B
14.99%
Instruments
2.83B
12.54%
Knees
2.44B
10.82%
Other
6.56B
29.05%
By RegionUSD
Name
Revenue
Proportion
United States
16.94B
74.98%
Europe & Middle East & Africa (EMEA) (Region)
2.89B
12.82%
Asia Pacific (Region)
2.02B
8.94%
Other countries
735.00M
3.25%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Medical
3.85B
17.04%
Trauma and Extremities
3.50B
15.52%
Endoscopy
3.38B
14.99%
Instruments
2.83B
12.54%
Knees
2.44B
10.82%
Other
6.56B
29.05%
Shareholder
Update time: Fri, Feb 21
Update time: Fri, Feb 21
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
The Vanguard Group, Inc.
8.53%
Brown (John W)
5.25%
Greenleaf Trust
4.65%
BlackRock Institutional Trust Company, N.A.
4.34%
State Street Global Advisors (US)
3.87%
Other
73.34%
Shareholder Statistics
Shareholder
Proportion
The Vanguard Group, Inc.
8.53%
Brown (John W)
5.25%
Greenleaf Trust
4.65%
BlackRock Institutional Trust Company, N.A.
4.34%
State Street Global Advisors (US)
3.87%
Other
73.34%
Type
Shareholder
Proportion
Investment Advisor
35.83%
Investment Advisor/Hedge Fund
29.72%
Bank and Trust
6.75%
Individual Investor
5.37%
Research Firm
2.99%
Pension Fund
1.97%
Sovereign Wealth Fund
1.33%
Hedge Fund
0.85%
Foundation
0.17%
Other
14.95%
Institutional Shareholding
Update time: Thu, Feb 20
Update time: Thu, Feb 20
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
3300
325.71M
85.36%
-6.19M
2024Q4
3392
326.30M
85.52%
-6.25M
2024Q3
3219
327.27M
85.85%
-2.63M
2024Q2
3172
322.05M
84.52%
-4.86M
2024Q1
3130
320.11M
84.03%
-8.54M
2023Q4
3047
327.61M
86.24%
+19.83M
2023Q3
2938
324.91M
85.54%
+14.80M
2023Q2
2898
325.03M
85.60%
+10.05M
2023Q1
2838
330.32M
87.03%
+17.40M
2022Q4
2800
311.06M
82.21%
-3.07M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
32.54M
8.53%
+257.03K
+0.79%
Dec 31, 2024
Brown (John W)
20.05M
5.25%
--
--
Feb 29, 2024
Greenleaf Trust
17.74M
4.65%
-780.06K
-4.21%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
16.58M
4.34%
-688.55K
-3.98%
Dec 31, 2024
State Street Global Advisors (US)
14.77M
3.87%
+196.15K
+1.34%
Dec 31, 2024
T. Rowe Price Associates, Inc.
10.61M
2.78%
+48.98K
+0.46%
Dec 31, 2024
Wellington Management Company, LLP
8.37M
2.19%
-1.71M
-17.00%
Dec 31, 2024
Fidelity Management & Research Company LLC
7.37M
1.93%
+749.68K
+11.32%
Dec 31, 2024
Geode Capital Management, L.L.C.
7.07M
1.85%
+168.43K
+2.43%
Dec 31, 2024
Capital Research Global Investors
6.84M
1.79%
-210.55K
-2.98%
Dec 31, 2024
View more
Related ETFs
Update time: Wed, Mar 5
Update time: Wed, Mar 5
Name
Proportion
Jensen Quality Growth ETF
7.08%
iShares U.S. Medical Devices ETF
4.7%
AdvisorShares Focused Equity ETF
4.24%
Democratic Large Cap Core ETF
3.3%
Gabelli Growth Innovators ETF
3.11%
JPMorgan Healthcare Leaders ETF
3.08%
Global X Aging Population ETF
3.07%
Health Care Select Sector SPDR Fund
2.69%
Tema Neuroscience and Mental Health ETF
2.5%
iShares U.S. Healthcare ETF
2.47%
View more
Jensen Quality Growth ETF
Proportion7.08%
iShares U.S. Medical Devices ETF
Proportion4.7%
AdvisorShares Focused Equity ETF
Proportion4.24%
Democratic Large Cap Core ETF
Proportion3.3%
Gabelli Growth Innovators ETF
Proportion3.11%
JPMorgan Healthcare Leaders ETF
Proportion3.08%
Global X Aging Population ETF
Proportion3.07%
Health Care Select Sector SPDR Fund
Proportion2.69%
Tema Neuroscience and Mental Health ETF
Proportion2.5%
iShares U.S. Healthcare ETF
Proportion2.47%
Dividend
A total of 5.22B USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Dec 10, 2024
SYK.NB Final Cash Dividend of gross USD 0.84 paid on Jan 31, 2025 going ex on Dec 31, 2024
Dec 31, 2024
Jan 31, 2025
Dec 31, 2024
Aug 07, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Oct 31, 2024 going ex on Sep 30, 2024
Sep 30, 2024
Oct 31, 2024
Sep 30, 2024
May 09, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Jul 31, 2024 going ex on Jun 28, 2024
Jun 28, 2024
Jul 31, 2024
Jun 28, 2024
Feb 07, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Apr 30, 2024 going ex on Mar 27, 2024
Mar 29, 2024
Apr 30, 2024
Mar 27, 2024
Dec 05, 2023
SYK.NB Final Cash Dividend of gross USD 0.8 paid on Jan 31, 2024 going ex on Dec 28, 2023
Dec 29, 2023
Jan 31, 2024
Dec 28, 2023
Aug 02, 2023
SYK.NB Interim Cash Dividend of gross USD 0.75 paid on Oct 31, 2023 going ex on Sep 28, 2023
Sep 29, 2023
Oct 31, 2023
Sep 28, 2023
May 10, 2023
SYK.NB Interim Cash Dividend of gross USD 0.75 paid on Jul 31, 2023 going ex on Jun 29, 2023
Jun 30, 2023
Jul 31, 2023
Jun 29, 2023
Feb 09, 2023
SYK.NB Interim Cash Dividend of gross USD 0.75 paid on Apr 28, 2023 going ex on Mar 30, 2023
Mar 31, 2023
Apr 28, 2023
Mar 30, 2023
Dec 07, 2022
SYK.NB Final Cash Dividend of gross USD 0.75 paid on Jan 31, 2023 going ex on Dec 29, 2022
Dec 30, 2022
Jan 31, 2023
Dec 29, 2022
Aug 03, 2022
SYK.NB Interim Cash Dividend of gross USD 0.695 paid on Oct 31, 2022 going ex on Sep 29, 2022
Sep 30, 2022
Oct 31, 2022
Sep 29, 2022
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
tradingkey.logo
tradingkey.logo
Intraday Data provided by Refinitiv and subject to terms of use. Historical and current end-of-day data provided by Refinitiv. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
* References, analysis, and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgement of the analyst, without considering the investment objectives and financial situation of the investors.
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.